https://www.selleckchem.com/pr....oducts/enpp-1-in-1.h
Continuous processing offers a promising approach to revolutionize biotherapeutics manufacturing as reflected in recent years. offers a comparative economic assessment of batch and continuous processing for the production of biotherapeutic products. Granulocyte-colony stimulating factor (GCSF), a protein expressed in E. coli, and an IgG1 monoclonal antibody, were chosen as representatives of microbial and mammalian derived products for this assessment. Economic indicators-cost of goods (COGs), net present value (NPV), and payback ti
Like
Comment
Share
